The purpose of this legislation is to nullify a specific rule from the Department of Health and Human Services regarding the treatment of opioid use disorder. The main objective is to ensure that most parts of this rule do not take effect, while allowing one specific aspect related to the accreditation of opioid treatment programs to remain in place. The key provision of this legislation states that the final rule titled "Medications for the Treatment of Opioid Use Disorder," which was published in February 2024, will not be enforced.